Bio & Insurance Information

Dr. Anthony El-Khoueiry is a medical oncology specialist in Los Angeles, California and he works at several hospitals in the area, such as Keck Medical Center of USC and USC Norris Cancer Hospital. He got his diploma from Keck School of Medicine of USC and did his residency in Internal Medicine at the University of Southern California - LAC+USC Medical Center. Dr. Anthony El-Khoueiry also completed three fellowships in Hematology and Medical Oncology at the University of Southern California - LAC+USC Medical Center. The doctor has an experience of more than 20 years.



Education & Training

Keck of USC

Medical School

University of Southern California - LAC+USC Medical Center

Residency

University of Southern California - LAC+USC Medical Center

Fellowship

Board Certifications

American Board of Internal Medicine - Oncology

Medical License

CA State Medical License: 2000 - 2018

Hospitals & Clinics

Keck Hospital of USC - Medical Center

Languages: English/Spanish

(323) 442-8500

1500 San Pablo St

Los Angeles, California 90033

Read More

USC Norris Comprehensive Cancer Center

Languages: English/Spanish

(323) 865-3000

1441 Eastlake Avenue

Los Angeles, California 90033

Read More

Publications

Dr. Anthony El-Khoueiry has contributed to 3 publications.

Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients.

Ning Y, Zhang W, Hanna DL, Yang D, Okazaki S, Berger MD, Miyamoto Y, Suenaga M, Schirripa M, El-Khoueiry A, Lenz H; Pharmacogenomics J.. 2016-08-09.

See more >>

A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer.

Adjei AA, Richards DA, El-Khoueiry A, Braiteh F, Becerra CHR, Stephenson JJ, Hezel AF, Sherman M, Garbo L, Leffingwell DP, Iverson C, Miner JN, Shen Z, Yeh L, Gunawan ...; Clin. Cancer Res.. 2016-05-15.

See more >>

Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.

Kuang, Y.,El-Khoueiry, A.,Taverna, P.,Ljungman, M.,Neamati, N.; Mol Oncol. 2015 Jul 15.

See more >>

Memberships

American Society of Clinical Oncology